QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
NYSE:AVNS

Avanos Medical - AVNS Price Target & Analyst Ratings

$28.92
+0.35 (+1.23%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$28.79
▼
$29.37
50-Day Range
$27.22
▼
$31.75
52-Week Range
$19.32
▼
$34.83
Volume
247,507 shs
Average Volume
256,147 shs
Market Capitalization
$1.35 billion
P/E Ratio
27.54
Dividend Yield
N/A
Price Target
$30.00

Avanos Medical Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 2 Analyst Ratings

Consensus Analyst Price Target

$30.00
3.73% Upside
High Prediction$34.00
Average Prediction$30.00
Low Prediction$28.00
TypeCurrent
3/27/22 to 3/27/23		1 Month Ago
2/25/22 to 2/25/23		3 Months Ago
12/27/21 to 12/27/22		1 Year Ago
3/27/21 to 3/27/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$30.00$30.00$28.67$40.67
Predicted Upside3.73% Upside14.32% Upside25.50% Upside18.29% Upside
Get Avanos Medical Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter.

AVNS Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AVNS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Avanos Medical Stock vs. The Competition

TypeAvanos MedicalMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.64
2.47
Consensus RatingHoldBuyHold
Predicted Upside3.73% Upside2,002.72% Upside22.47% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/22/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetUnderweight$26.00 ➝ $28.00-3.48%
11/3/2022KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOverweight$38.00 ➝ $34.00+46.74%
7/18/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$37.00 ➝ $28.00+4.28%
8/4/2021Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOverweight ➝ Equal Weight$60.00 ➝ $45.00+21.85%
4/13/2020Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeUnderweight ➝ Equal Weight$30.00+3.63%
(Data available from 3/27/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












AVNS Price Target - Frequently Asked Questions

What is Avanos Medical's consensus rating and price target?

According to the issued ratings of 2 analysts in the last year, the consensus rating for Avanos Medical stock is Hold based on the current 1 sell rating and 1 buy rating for AVNS. The average twelve-month price prediction for Avanos Medical is $30.00 with a high price target of $34.00 and a low price target of $28.00. Learn more on AVNS's analyst rating history.

Do Wall Street analysts like Avanos Medical more than its competitors?

Analysts like Avanos Medical less than other Medical companies. The consensus rating for Avanos Medical is Hold while the average consensus rating for medical companies is Buy. Learn more on how AVNS compares to other companies.

Does Avanos Medical's stock price have much upside?

According to analysts, Avanos Medical's stock has a predicted upside of 14.32% based on their 12-month price targets.

What analysts cover Avanos Medical?

Avanos Medical has been rated by Morgan Stanley in the past 90 days.


Stock Ratings Reports and Tools

Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
Ratings for Popular Stocks:
This page (NYSE:AVNS) was last updated on 3/27/2023 by MarketBeat.com Staff